Aimee Kestranek
Chief Operating Officer

Aimee Kestranek is a seasoned biotech professional whose 25 years’ experience spans management, R&D, regulatory filing, quality systems, product development, lab operations and commercialization. At Cleveland Diagnostics, she is a consummate problem solver who has led the commercial development of the company’s lead product, IsoPSA®, including tech transfer and FDA submission. Aimee is a graduate of Penn State University and trained as an analytical chemist with extensive experience in the pharmaceutical industry. On the other side of the bench, she has built successful client relationships, including with top-tier pharmaceutical organizations in a highly complex, evolving business climate.